3-Bromo-6-hydrazinyl-2-methylpyridine

Catalog No.: 
ACMUDS078
CAS No.: 
39919-66-9
Molecular Formula: 
C6H8BrN3
Molecular Weight: 
202.05
3-Bromo-6-hydrazinyl-2-methylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$175.00InquiryInquiry
5g98%$474.00InquiryInquiry
10g98%$832.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6-hydrazinyl-2-methylpyridine
IUPAC Name3-bromo-6-hydrazineyl-2-methylpyridine
MDL No.MFCD10000078
Molecular FormulaC6H8BrN3
Molecular Weight202.05
SMILESCC1=NC(NN)=CC=C1Br
InChI KeyWQIMBATZAFAPJX-UHFFFAOYSA-N
Synonym3-Bromo-6-hydrazinyl-2-methylpyridine;(5-Bromo-6-methyl-pyridin-2-yl)-hydrazine;Pyridine, 3-bromo-6-hydrazinyl-2-methyl-
CAS No.39919-66-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMUDS078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUMDW493 route compound structure diagram
    ACUMDW49339919-65-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMUDS078 route product structure diagram
    ACMUDS07839919-66-9
Inquiry

2. ACMUDS078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHRPX923 route compound structure diagram
    ACHRPX923132606-40-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMUDS078 route product structure diagram
    ACMUDS07839919-66-9
Inquiry

3. ACMUDS078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKLBZ206 route compound structure diagram
    ACKLBZ206375368-83-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMUDS078 route product structure diagram
    ACMUDS07839919-66-9
Inquiry

Comments (0)